rss
Br J Ophthalmol 2006;90:1425-1429 doi:10.1136/bjo.2006.096420
  • Laboratory science - Extended reports

Detection by broad-range real-time PCR assay of Chlamydia species infecting human and animals

  1. P Goldschmidt1,
  2. H Rostane1,
  3. M Sow2,
  4. A Goépogui3,
  5. L Batellier1,
  6. C Chaumeil1
  1. 1Centre Hospitalier National d’Ophtalmologie des Quinze Vingts, Paris, France
  2. 2Hôpital de Kankan, Guinea, France
  3. 3Hôpital Donka de Conakry, Guinea
  1. Correspondence to: P Goldschmidt Laboratoire du Centre Hospitalier National d’Ophtalmologie des Quinze Vingts, 28 rue de Charenton, 75012 Paris, France; pablogol{at}aol.com
  • Accepted 3 June 2006
  • Published Online First 9 August 2006

Abstract

Background: Tests available for molecular diagnosis of chlamydial infections detect Chlamydiatrachomatis, but do not find other Chlamydia species associated with genital, ophthalmic, cardiovascular, respiratory or neurological diseases. The routine detection of all Chlamydia species would improve the prognosis of infected people and guide therapeutic choices.

Aim: To design and validate a sensitive, specific, reproducible, inexpensive and easy-to-perform assay to quantify most Chlamydia species.

Methods: Primers and probe were selected using the gene coding for the 16S rRNA. The detection limits were assessed for suspensions of Chlamydia trachomatis, Chlamydia psittaci and Chlamydia pneumoniae. The performance of this test was compared with that of two commercial kits (Amplicor-Roche and Artus) on 100 samples obtained from children with trachoma.

Results: The detection capacities for Chlamydia trachomatis of the broad-range real-time polymerase chain reaction (PCR) were similar or slightly better than those obtained with commercial kits (0.2 copies of DNA/μl). Only the broad-range PCR identified specimens containing Chlamydia psittaci and Chlamydia pneumoniae. The commercial kits and the broad-range assay detected Chlamydia species in 5% and in 11%, respectively, of samples from children with trachoma.

Conclusions: This new real-time PCR offers a sensitive, reproducible assay that produces results in <3 h. With panels of quantified Chlamydia species, this real-time PCR can be run with all real-time PCR equipment. Larger trials are needed to confirm the utility of this test in diagnosis and for therapeutic follow-up.

Footnotes

  • Published Online First 9 August 2006

  • Competing interests: None declared.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All Versions of this Article:
    1. bjo.2006.096420v1
    2. 90/11/1425 most recent

Responses

  1. Submit a response
  2. No responses published

Social bookmarking

Register for free content


Free sample
 This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Free archive
The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.